Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S196. Epub 2015 Aug 5.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Area Under Curve
  • Bosentan
  • Capillaries / drug effects*
  • Capillaries / pathology
  • Endothelin Receptor Antagonists / therapeutic use*
  • Female
  • Humans
  • Italy
  • Male
  • Microscopic Angioscopy*
  • Middle Aged
  • Predictive Value of Tests
  • ROC Curve
  • Recurrence
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy*
  • Secondary Prevention / methods*
  • Skin / blood supply*
  • Skin Ulcer / diagnosis
  • Skin Ulcer / drug therapy*
  • Skin Ulcer / etiology
  • Sulfonamides / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Endothelin Receptor Antagonists
  • Sulfonamides
  • Bosentan